BML Investment Partners, L.P. - Feb 26, 2025 SCHEDULE 13G Report for LAVA Therapeutics N.V. Common shares, par value $0.14 per share (LVTX)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: LAVA Therapeutics N.V. Common shares, par value $0.14 per share
Symbol: LVTX
Shares outstanding: 26.5M shares
Disclosed Ownership: 1.96M shares
Ownership: 7.4%
Form type: SCHEDULE 13G
Date filed: 3/3/2025, 02:03 PM
Date of event: Feb 26, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	7.4%	1.96M	0	1.96M	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member